Back to Search
IRENE KUTER, MD DPHIL
MD DPHIL
Hematology (Internal Medicine) Physician
NPI: 1629052410IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
50927(MA)
Education
HARVARD MEDICAL SCHOOL
Class of 1978
Research & Publications (14)
VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy.
PMID 19047116·Clin Cancer Res·2008
3-trial
Survival in patients with brain metastases from breast cancer: the importance of HER-2 status.
PMID 18361426·Cancer·2008
3-trial
Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer.
PMID 16243442·Int J Radiat Oncol Biol Phys·2006
3-trial
Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implications.
PMID 15774788·J Clin Oncol·2005
3-trial
Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer.
PMID 15728611·AJR Am J Roentgenol·2005
4-observational
Nitric oxide as a prognostic marker for neurological diseases.
PMID 15130288·Antioxid Redox Signal·2004
7-preclinical
Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
PMID 12784331·Cancer·2003
8-other
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study.
PMID 12506169·J Clin Oncol·2003
3-trial
Immunologic quantitation of the carcinoma specific human carcinoma antigen in clinical samples.
PMID 11857316·Cancer·2002
7-preclinical
Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel.
PMID 11734597·J Natl Cancer Inst·2001
8-other
Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer.
PMID 11352965·J Clin Oncol·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 55 FRUIT ST, YAWKEY 9A
BOSTON, MA 02114 - Phone
- (617) 726-6500
Quick Facts
- NPI
- 1629052410
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 48
- Publications
- 14
Are you this provider?
Claim Your Profile